Clinical phenotypes of cardiotoxicity in breast cancer patients undergoing contemporary oncologic therapy
Distinct and clinically interpretable cardiotoxicity phenotypes can be identified among breast cancer patients receiving contemporary oncologic therapy and may enable personalized, risk-adapted surveillance strategies and facilitate earlier, targeted cardioprotective interventions in cardio-oncology practice.